| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Atherosclerosis |
From the Division of Cardiovascular and Respiratory Medicine, Department of Internal Medicine (Y.R., K.H., T.Y., K.I., M.O., J.E., N.I., S. Kawashima, M.Y.) and Department of Surgical Pathology (S. Kobayashi, H.I.), Kobe University Graduate School of Medicine, and the Institute for Experimental Animals (M.S.), Kobe University School of Medicine, Kobe, Japan.
Correspondence to Mitsuhiro Yokoyama, MD, PhD, Professor, Division of Cardiovascular and Respiratory Medicine, Department of Internal Medicine, Kobe University Graduate School of Medicine, 7-5-1, Kusunoki-cho, Chuo-ku, Kobe, 650-0017, Japan. E-mail yokoyama{at}med.kobe-u.ac.jp
Abstract
Objective Lysophosphatidylcholine (LPC), a major phospholipid component of oxidized low density lipoprotein, has been demonstrated to induce multiple functional alterations of vasculature that are potentially involved in atherosclerosis. Recently, an orphan G-protein-coupled receptor, G2A, has been identified as a high-affinity receptor for LPC. Although it has been demonstrated that G2A is expressed predominantly in lymphoid tissues and lymphocytes, there are no reports to determine whether G2A is expressed in atherosclerotic lesions and cardiovascular cells.
Methods and Results Immunohistochemistry with an anti-G2A antibody revealed that G2A was expressed predominantly by macrophages within atherosclerotic lesions at the aortic root of apolipoprotein E-deficient mice and the thoracic aortas of Watanabe heritable hyperlipidemic rabbits. In atherosclerotic plaques of human coronary arterial specimens, G2A was expressed by macrophages within the lipid-rich plaques, whereas no immunoreactivity of G2A was observed in fibrous plaques where macrophages did not exist. Reverse transcription-polymerase chain reaction analysis demonstrated that G2A mRNA was highly expressed in human and murine monocytes/macrophages. The expression of G2A protein was detected in human and murine monocytes/macrophages by immunoblotting.
Conclusions These findings demonstrate that monocytes/macrophages abundantly express G2A and suggest that G2A may play a role in the formation and progression of atherosclerotic lesions.
Key Words: atherosclerosis lipids plaque receptors
This article has been cited by other articles:
![]() |
D. T. Bolick, M. D. Skaflen, L. E. Johnson, S.-C. Kwon, D. Howatt, A. Daugherty, K. S. Ravichandran, and C. C. Hedrick G2A Deficiency in Mice Promotes Macrophage Activation and Atherosclerosis Circ. Res., February 13, 2009; 104(3): 318 - 327. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. K. Jackson, W. Abate, J. Parton, S. Jones, and J. L. Harwood Lysophospholipid metabolism facilitates Toll-like receptor 4 membrane translocation to regulate the inflammatory response J. Leukoc. Biol., July 1, 2008; 84(1): 86 - 92. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. T. Bolick, A. M. Whetzel, M. Skaflen, T. L. Deem, J. Lee, and C. C. Hedrick Absence of the G Protein-Coupled Receptor G2A in Mice Promotes Monocyte/Endothelial Interactions in Aorta Circ. Res., March 2, 2007; 100(4): 572 - 580. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Qiu, A. C. Ho, W. Yu, and J. S. Hill Suppression of endothelial or lipoprotein lipase in THP-1 macrophages attenuates proinflammatory cytokine secretion J. Lipid Res., February 1, 2007; 48(2): 385 - 394. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Fujita, M. Yoshizumi, Y. Izawa, N. Ali, H. Ohnishi, Y. Kanematsu, K. Ishizawa, K. Tsuchiya, and T. Tamaki Transactivation of Fetal Liver Kinase-1/Kinase-Insert Domain-Containing Receptor by Lysophosphatidylcholine Induces Vascular Endothelial Cell Proliferation Endocrinology, March 1, 2006; 147(3): 1377 - 1385. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Obinata, T. Hattori, S. Nakane, K. Tatei, and T. Izumi Identification of 9-Hydroxyoctadecadienoic Acid and Other Oxidized Free Fatty Acids as Ligands of the G Protein-coupled Receptor G2A J. Biol. Chem., December 9, 2005; 280(49): 40676 - 40683. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Zalewski and C. Macphee Role of Lipoprotein-Associated Phospholipase A2 in Atherosclerosis: Biology, Epidemiology, and Possible Therapeutic Target Arterioscler Thromb Vasc Biol, May 1, 2005; 25(5): 923 - 931. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. V. Yang, C. G. Radu, L. Wang, M. Riedinger, and O. N. Witte Gi-independent macrophage chemotaxis to lysophosphatidylcholine via the immunoregulatory GPCR G2A Blood, February 1, 2005; 105(3): 1127 - 1134. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Murakami, T. Yokomizo, T. Okuno, and T. Shimizu G2A Is a Proton-sensing G-protein-coupled Receptor Antagonized by Lysophosphatidylcholine J. Biol. Chem., October 8, 2004; 279(41): 42484 - 42491. [Abstract] [Full Text] [PDF] |
||||
|
ATVB Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2002 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |